Clinical Trials
55 trialsCMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
BREATHS
University College, London
PULSE
Dana-Farber Cancer Institute
CARE-BREAST
University of Castilla-La Mancha
BE-FITTER
University of Alberta
HIMALAYAS-P
University Health Network, Toronto
HIMALAYAS
University Health Network, Toronto
ATOPE
Universidad de Granada
DETECT
Assistance Publique - Hôpitaux de Paris
Exercise Preconditioning in Ovarian Cancer
University of Virginia
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
TRUST-ACE
Norwegian University of Science and Technology
CorTox
Technische Universität Dresden
JUSTIFY
Women's College Hospital
HER2BIC
Odense University Hospital
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
CARPTOX-BC
Instituto Nacional de Cardiologia Ignacio Chavez
SpeckleAnthra2
University Hospital, Montpellier
CARMA
Cedars-Sinai Medical Center
CAVACI
Algemeen Ziekenhuis Maria Middelares
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
PROTECT-COR
Erasmus Medical Center
Exercise for Ameliorating Chemotherapy Cardiotoxicity
University of Hull
EXACT2
Nova Scotia Health Authority
CATCH
Vejle Hospital
CardioProtEx
Technical University of Madrid
LYMfit
Norwegian School of Sport Sciences
Cardiotoxicity Monitoring With Single-lead Electrocardiogram
I.M. Sechenov First Moscow State Medical University
ECHOS2
Washington University School of Medicine
HER-SAFE
University College, London
IRAF-ISCM
University Hospital, Caen
BRAVEHeart
University of Sydney
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
ONCORE
Hospital Clinico Universitario de Santiago
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
Ruijin Hospital
EDIPE
Institut de cancérologie Strasbourg Europe
Remote Ischaemic Preconditioning in Childhood Cancer
The University of Hong Kong
ANKE
Heinrich-Heine University, Duesseldorf
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
D'Or Institute for Research and Education
CA2D
University Hospital, Bordeaux
CANFLAX
St. Boniface Hospital
Exercise Response After Revalidation in Cancer Patients
Universitair Ziekenhuis Brussel
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Samsung Medical Center
ERIC-ONC
University College, London
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
University of Athens
Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment
University of Sao Paulo General Hospital